377 related articles for article (PubMed ID: 1692065)
1. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
2. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
3. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
[TBL] [Abstract][Full Text] [Related]
6. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
Warner JA; MacGlashan DW
J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
[TBL] [Abstract][Full Text] [Related]
8. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
Casolaro V; Spadaro G; Patella V; Marone G
J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
12. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of mediator release from human basophils induced by platelet-activating factor.
Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect of cyclosporin A on human skin mast cells.
Stellato C; de Paulis A; Ciccarelli A; Cirillo R; Patella V; Casolaro V; Marone G
J Invest Dermatol; 1992 May; 98(5):800-4. PubMed ID: 1373749
[TBL] [Abstract][Full Text] [Related]
15. The effect of pertussis toxin on mediator release from human basophils.
Warner JA; Yancey KB; MacGlashan DW
J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes.
Hultsch T; Rodriguez JL; Kaliner MA; Hohman RJ
J Immunol; 1990 Apr; 144(7):2659-64. PubMed ID: 1690774
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
18. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V; Casolaro V; Björck L; Marone G
J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
[TBL] [Abstract][Full Text] [Related]
19. The antineoplastic bryostatins affect human basophils and mast cells differently.
Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
